Drug
Imp
Imp: highest development phase Post-Market, developed by AstraZeneca. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- AstraZeneca
Trials
| Drug | Phase | Indication |
|---|---|---|
| IMP oral tablet NCT04219124 | Post-Market | Type 2 Diabetes |
Latest
No recent events.
Follow Imp on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.